{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:59:19Z","timestamp":1793350759784,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103333","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:37:56Z","timestamp":1781224676000},"page":"103333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Xianlu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1741-6446","authenticated-orcid":false,"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103333_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","article-title":"Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape","volume":"14","author":"Mohme","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103333_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-024-01625-7","article-title":"Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies","volume":"17","author":"Ai","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103333_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(25)00553-7","article-title":"Cancer vaccines and the future of immunotherapy","volume":"406","author":"Pail","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2026.103333_bib4","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ccell.2023.07.011","article-title":"Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy","volume":"41","author":"Topalian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103333_bib5","article-title":"Bladder cancer immunotherapy parallel advances in BCG optimization and next-generation vaccine platforms","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103333_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cncy.22603","article-title":"Insights on recent innovations in bladder cancer immunotherapy","volume":"130","author":"Abd El-Salam","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.mtbio.2026.103333_bib7","article-title":"Bladder cancer: immunotherapy and pelvic lymph node dissection","volume":"12","author":"Fan","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mtbio.2026.103333_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303835","article-title":"Extracellular vesicles-derived hybrid nanoplatforms for amplified CD47 blockade-based cancer immunotherapy","volume":"35","author":"Tang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103333_bib10","article-title":"Bioinspired and biomimetic cancer-cell-derived membrane nanovesicles for preclinical tumor-targeted nanotheranostics","volume":"4","author":"Prasad","year":"2023","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.mtbio.2026.103333_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116798","article-title":"Nanotechnology-based approaches for antibacterial therapy","volume":"279","author":"Dong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mtbio.2026.103333_bib12","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","article-title":"Dendritic cell-derived exosomes for cancer therapy","volume":"126","author":"Pitt","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mtbio.2026.103333_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2026.103333_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","article-title":"Cellular functions of cGAS-STING signaling","volume":"33","author":"Chen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103333_bib16","first-page":"345","article-title":"STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy","volume":"42","author":"Nguyen","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2026.103333_bib17","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/acs.accounts.3c00394","article-title":"Engineering and delivery of cGAS-STING immunomodulators for the immunotherapy of cancer and autoimmune diseases","volume":"56","author":"Zhou","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mtbio.2026.103333_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26189008","article-title":"STINGing cancer: development, clinical application, and targeted delivery of STING agonists","volume":"26","author":"Nerdinger","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103333_bib19","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1021\/acsnano.3c11374","article-title":"Self-assembled STING-activating coordination nanoparticles for cancer immunotherapy and vaccine applications","volume":"18","author":"Sun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103333_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12967-021-03061-4","article-title":"Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses","volume":"19","author":"Sun","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103333_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006667","article-title":"Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001188","article-title":"Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib24","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103333_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mtbio.2026.103333_bib26","article-title":"Rapid generation of hPSC-Derived high endothelial venule organoids with in vivo ectopic lymphoid tissue capabilities","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103333_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.humimm.2020.04.007","article-title":"Novel immunological approach to asses donor reactivity of transplant recipients using a humanized mouse model","volume":"81","author":"Fukasaku","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.mtbio.2026.103333_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/cac2.12465","article-title":"Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors","volume":"43","author":"Chen","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.mtbio.2026.103333_bib29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41590-025-02259-8","article-title":"Simultaneous STING and lymphotoxin-\u03b2 receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity","volume":"26","author":"Sawada","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2026.103333_bib30","doi-asserted-by":"crossref","first-page":"eadk2612","DOI":"10.1126\/sciimmunol.adk2612","article-title":"cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation","volume":"9","author":"Zhao","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.mtbio.2026.103333_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112586","article-title":"Cell-derived artificial nanovesicle as a drug delivery system for malignant melanoma treatment","volume":"147","author":"Lin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.103333_bib32","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1021\/acs.nanolett.5c00986","article-title":"Epigenetically reprogrammed nanovesicles as inverse vaccines for antigen-specific immune tolerance in autoimmune diseases","volume":"25","author":"Xi","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103333_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.talanta.2005.02.018","article-title":"Protein G-liposomal nanovesicles as universal reagents for immunoassays","volume":"67","author":"Chen","year":"2005","journal-title":"Talanta"},{"key":"10.1016\/j.mtbio.2026.103333_bib34","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1021\/acsnano.4c14102","article-title":"Reprogramming the tolerogenic immune response against pancreatic cancer metastases by lipid nanoparticles delivering a STING agonist plus mutant KRAS mRNA","volume":"19","author":"Xu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103333_bib35","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","volume":"15","author":"Shao","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103333_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib37","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103333_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib39","doi-asserted-by":"crossref","first-page":"eadz5078","DOI":"10.1126\/sciadv.adz5078","article-title":"Self-transforming hydrogel mimicking tertiary lymph nodes to activate cGAS-STING pathway for enhanced antitumor immunotherapy","volume":"12","author":"Wang","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103333_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.103333_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2026.103333_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-Gebologlu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103333_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10142-022-00884-2","article-title":"In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Funct. Integr. Genomics"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426005788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426005788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:16Z","timestamp":1787026696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426005788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S2590006426005788"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103333","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103333"}}